the present study was undertaken to characterize the cardiac electrophysiologic effects of the investigational class i antiarrhythmic agent recainam ( wy-42,362 ) on the canine heart in situ , and to determine the possible relationship between these effects and the concentration of drug in plasma and myocardium .
C0018787
heart
C0027061
myocardium